Plain-English translation of NCT02984761 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether stereotactic radiotherapy (a focused, high-dose radiation treatment) works as well as lung surgery for treating early-stage non-small cell lung cancer. Currently, surgery is the standard treatment for patients healthy enough to have an operation, but newer research suggests that stereotactic radiotherapy may be an effective alternative. This study will randomly assign patients to receive one of these two treatments and follow them for at least 5 years to compare which approach helps people live longer.
While some recent studies hint that stereotactic radiotherapy might work better than surgery, other studies suggest surgery is equal or superior. This trial exists to give a clear, definitive answer by comparing these two treatments head-to-head in a large group of patients, so doctors and patients can make the best treatment choice.
You likely qualify if…
You likely don't qualify if…
If you enroll, your medical team will first confirm your diagnosis with biopsies and imaging scans (including PET-CT scans). You'll meet with thoracic surgeons and radiation doctors who will evaluate whether you're a candidate for both treatments. Then you'll be randomly assigned to either have lung surgery (removal of part or all of one lung under general anesthesia) or receive stereotactic radiotherapy (focused radiation given over several outpatient visits). After your treatment, you'll be followed closely for at least 5 years with regular check-ups and imaging to monitor your health and survival.
AI-generated summary from trial data · Aug 14, 2026 · Not medical advice
United States